Prevest Denpro Ltd

Prevest Denpro Ltd, a micro-cap player in the Healthcare Services sector, has touched a new 52-week low of Rs.365.6 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its valuation and performance metrics.

Prevest Denpro Ltd, a micro-cap player in the Healthcare Services sector, touched a new 52-week low of Rs.393 today, marking a significant decline in its share price amid broader market pressures and company-specific factors.

Prevest Denpro Ltd, a player in the Healthcare Services sector, has touched a new 52-week low of Rs.393 today, marking a significant decline in its stock price amid broader market volatility and sectoral pressures.

Prevest Denpro Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Prevest Denpro Ltd, a key player in the healthcare services sector, has experienced a notable shift in its technical momentum, prompting a downgrade in its Mojo Grade from Hold to Sell as of 6 Nov 2025. The stock’s recent price action and technical indicators suggest increasing bearish pressure, with the share price declining 2.29% on 9 Mar 2026 to ₹425.00, reflecting a broader negative sentiment in the market.

Prevest Denpro Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 February 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Prevest Denpro Ltd, a key player in the Healthcare Services sector, has seen a marked shift in its valuation parameters, moving from an expensive to a very expensive rating. This change, coupled with a recent downgrade in its Mojo Grade from Hold to Sell, highlights growing concerns over the stock’s price attractiveness relative to its historical and peer benchmarks.

Prevest Denpro Ltd, a healthcare services company, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish indicators. Despite a recent upgrade from Hold to Sell by MarketsMOJO, the stock’s price action and technical parameters reveal a landscape of cautious optimism tempered by persistent downward pressures.

Prevest Denpro Ltd, a key player in the Healthcare Services sector, has experienced a notable shift in its valuation parameters, moving from a 'very expensive' to an 'expensive' rating. This change, coupled with a recent downgrade in its Mojo Grade from Hold to Sell, reflects evolving market perceptions and raises questions about the stock's price attractiveness relative to its historical and peer benchmarks.

Prevest Denpro Ltd, a micro-cap player in the Healthcare Services sector, has witnessed a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s current market dynamics reflect a deteriorating technical outlook, compounded by a recent downgrade in its Mojo Grade from Hold to Sell, underscoring growing investor caution.

Prevest Denpro Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Prevest Denpro Ltd, a key player in the Healthcare Services sector, has exhibited a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent upgrade in price momentum from bearish to mildly bearish, the stock’s technical indicators present a nuanced picture that investors should carefully analyse before making decisions.

Prevest Denpro Ltd, a micro-cap player in the Healthcare Services sector, has experienced a notable shift in its valuation parameters, prompting a downgrade in its Mojo Grade from Hold to Sell. The company’s price-to-earnings (P/E) ratio and price-to-book value (P/BV) have moved from very expensive to expensive territory, reflecting a recalibration of price attractiveness relative to historical and peer benchmarks. This article analyses these valuation changes in detail, placing them in the context of sector trends and comparative company metrics.

Prevest Denpro Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 February 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Prevest Denpro Ltd’s valuation metrics have undergone a marked shift, moving from expensive to very expensive territory, raising concerns about price attractiveness for investors amid a challenging healthcare services sector backdrop. With a recent upgrade to a Sell rating and a Mojo Score of 30.0, the company’s elevated price-to-earnings and price-to-book ratios now stand out starkly against both historical averages and peer benchmarks.

Prevest Denpro Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 January 2026, providing investors with an up-to-date view of the company’s performance and outlook.